Atlas Trials

Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)

Clinical trial NCT02783729 · COMPLETED

Trial details

NCT number
NCT02783729
Sponsor
Eisai Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Insomnia
Start date
2016-05-31
Primary completion
2018-01-30
Enrollment
1006

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.